Skip to content


Pretomanid, Dovprela, Pretomanid FGK (pretomanid) is a small molecule pharmaceutical. Pretomanid was first approved as Pretomanid on 2019-08-14. It is used to treat extensively drug-resistant tuberculosis in the USA. It has been approved in Europe to treat multidrug-resistant tuberculosis.
Trade Name Dovprela, Pretomanid FGK
Common Name Pretomanid
Indication extensively drug-resistant tuberculosis, multidrug-resistant tuberculosis
Drug Class Mycolic acid inhibitors
Get full access now